Biogen to Participate in Upcoming Investor Conferences
Cambridge, MA, - - Biogen Inc. (Nasdaq: BIIB) announced today that Uptal Patel, Head of Biogen West Coast Hub, will participate in a panel during the Wedbush Virtual Nephrology Day. The webcast will be live on Monday, Nov 10, 2025, at 1:20 p.m. ET.
Additionally, Uptal Patel, Head of Biogen West Coast Hub, and Diana Gallagher, Head of Clinical Development, MS&I and AD, will participate in a fireside chat during the TD Cowen Immunology & Inflammation Summit. The webcast will be live on Thursday, Nov 13, 2025, at 4:30 p.m. ET.
To access the live webcasts, please visit the Investors section of Biogen’s website at investors.biogen.com. An archived version of the webcasts will be available for at least 30 days following the presentation.
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
We routinely post information that may be important to investors on our website at www.biogen.com. Follow us on social media - Facebook, LinkedIn, X, YouTube.
Contact:
Karen Jewell
Investor Relations
Biogen
781.464.2442
